Literature DB >> 35930572

Adherence to Covid-19 mitigation measures and its associated factors among health care workers at referral hospitals in Amhara regional state of Ethiopia.

Agazhe Aemro1, Beletech Fentie2, Mulugeta Wassie1.   

Abstract

INTRODUCTION: With fragile health care systems, sub-Saharan Africa countries like Ethiopia are facing a complex epidemic, and become difficult to control the noble coronavirus. The use of COVID-19 preventive measures is strongly recommended. This study aimed to assess the adherence of COVID-19 mitigation measures and associated factors among health care workers.
METHODS: A facility-based cross-sectional study was conducted among health care workers at referral hospitals in the Amhara regional state of Ethiopia from May 15 to June 10; 2021. It was a web-based study using an online questionnaire. STATA 14.2 was used for data analysis. Variables with a p-value<0.05 at 95% confidence level in multivariable analysis were declared as statistically significant using binary logistic regression. RESULT: Adherence to COVID-19 mitigation measures was 50.24% in the current study. The odd of adherence of participants with a monthly income of ≥12801birr was 15% whereas the odds of adherence of participants who hesitate to take the COVID 19 vaccine were 10% as compared to those who don't hesitate. Participants who had undergone COVID-19 tests adhered 6.64 times more than their counterparts. Those who believe adequate measurements are taken by the government adhered 4.6 times more than those who believe not adequate. Participants who believe as no risk of severe disease adhered 16% compared to those with fear of severe disease. Presence of households aged >60years adhered about 7.9 times more than with no households aged>60. Participants suspected of COVID-19 diagnosis adhered 5.7 times more than those not suspected.
CONCLUSION: In this study, a significant proportion of healthcare workers did not adhere to COVID-19 mitigation measures. Hence, giving special attention to healthcare workers with a monthly income of ≥12801 birr, being hesitant towards COVID-19 vaccine, being aged 26-30, and perceiving no risk of developing a severe infection is crucial to reduce non-adherence.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35930572      PMCID: PMC9355263          DOI: 10.1371/journal.pone.0272570

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

The pandemic of COVID-19 entered Africa continent by the termination of February 2020 afterward it was professed a public health emergency of Worldwide Concern by the world health organization [1]. With fragile health care systems, African countries like Ethiopia are facing a complex COVID-19 epidemic, and it becomes a unbreakable duty to switch the virus reservoir, from where the virus may be introduce again to other regions [2]. Globally, COVID-19 affected more than 119.7 million people and 2.6 million deaths occurred [3] whereas in Africa over 4 million cases and 107 thousand deaths have been confirmed [4]. Considering the pandemic and lack of efficient management, government regulators’ in the globe designed different mitigation methods to battle the spread of the pandemic [5, 6]. To control the pandemic transmission, world health organization endorses reducing contact, early identification and isolation of cases, personal and material hygiene measures [6, 7]. As part of these measures, the use of face masks, hand washing, physical distancing, cough etiquette, and avoidance of crowded places are strongly recommended [7]. Even though adherence to preventive measures is the only means to tackle the disease, reluctance to do so has been reported to be a major problem everywhere [8]. Health care professionals are facing more workload, mental distress, scarcity of quality personal protective equipment, social exclusion, absence of motivations, coordination and good leadership throughout their service [9]. The good adherence to the COVID-19 pandemic mitigation measures was 51.04% and 8.3% in different Ethiopian studies conducted in the general community, but there is no information among health care providers [5, 8]. A substantial number of health care workers were reported to be infected with COVID-19 within the first six months of the COVID-19 pandemic, with the occurrence of hospitalization of 15.1% and mortality of 1.5% [10]. Health care providers are also facing many challenges like physical and mental affects, stigma and discrimination, fear of infection, and overall trying their best to keep it together. Health care providers could forget the mitigation measures of COVID-19 due to high workload, stress and related factors which will cause significant disruption of prevention chains of the disease [11, 12]. As far our search, there is no research conducted among health care workers in the current study setting and it is also true in the country as large. Therefore, this study intended to assess the adherence of COVID-19 mitigation measures and their associated factors among health care providers in the Amhara region regional state of Ethiopia.

Methods and materials

Study design, period and setting

A facility-based cross-sectional study was conducted from May 15 to June 10; 2021. It was a Web-based anonymous study using an online questionnaire. The study was conducted at referral hospitals in the Amhara regional state. According to the Amhara national regional health bureau annual performance report, the region has 81 hospitals, 858 health centers, and 3560 health posts. Among the hospitals in the region, the University of Gondar, Dessie, Felege-Hiwot, Tibebe-Ghion, Debre-Markos, Waldiya, Debre Tabor, and Debre Berhan are referral hospitals (Fig 1). The health care professionals working in these hospitals are estimated to be 4,000 [13, 14].
Fig 1

Schematic presentation of referral hospitals in Amhara regional state, Ethiopia.

Study participants

Telegram and email (the most popular social media platforms in Ethiopia) were used to promote and circulate the survey link to the participants. Data collectors in each hospital were asked to distribute the survey link to the randomly selected contacts in each hospital. The participants were informed that their participation was based on voluntariness, and consent was implied through their completion of the questionnaire. The respondents working during the data collection period were included in the current study.

Sample size determination

The sample size was determined using the single population proportion formula taking the proportion of compliance to the COVID19 preventive measures 22% [15], 95% confidence interval, and 4% marginal error. After adding a 5% non-response rate, the final sample size was ⁓433.

Sampling procedure

There are about 4,000 health care workers in Amhara regional state referral hospitals(906 in Gondar hospital, 320 in Debre tabor hospital,255 in Tibebe Ghione hospital,917 in Felege Hiot hospital,430 in Debre Markos Hospital,604 in Dessie hospital,300 in Waldiya hospital and 270 in Debre Berhan hospital). The entire sample size was first allocated proportionally to those eight referral hospitals. In order to select study participants from each hospital, first, the list of active healthcare workers during the study period was taken from the human resource management office of each hospital. Since the data was collected using telegram or e-mail, healthcare workers with no recorded information at either of these two addresses were excluded from the study. After that, a random number was generated on the computer, and by using this number and based on the allocated sample size, study participants were selected. Finally, the link of the questionnaire was given to the data collectors and forwarded to randomly select health care workers of respected hospitals, using e-mail or telegram. The link was forwarded to each hospital’s data collector to avoid coverage bias and to be representative.

Operational definitions

Good adherence of COVID-19 mitigation measures

Adherence in the current study was measured as participants who adhered (responded “yes”) to all of the three basic preventive measures (Wearing a mask, keeping physical distancing of a minimum of 2 meters, and Handwashing a minimum of ≥6 times/ day) and measured ‘Yes’ or ‘No’ answers to the questions. The specific questions used to assess the adherence of mask wearing, hand washing and physical distancing were asked as “have you wear face mask every time you leave home and never remove it from the face? (Yes/ No), do you wash your hand with soap at least six times per day during the Covid-19 pandemic? (yes/no) and are you fully compliance with physical distancing (≥2 meter) during the Covid-19 pandemic?(Yes/no) respectively. Individual participants who respond “Yes” for each component were adhered for mitigation measures in the current study. Participants who did not adhere even one of the three components of the mitigation measures were considered not adhered at the whole. We have summed all the three components and calculated the whole adherence.

Health care worker (HCW)

Any member of the health care unit that includes medical doctors, pharmacists, physiotherapists, midwifery, laboratory technologists, nursing professionals, or any other person in the course of his or her professional activities who may prescribe, administer, or dispense a medicinal product to an end-user [16].

Vaccine hesitancy

World Health Organization (WHO) declared vaccine hesitancy as "the reluctance or refusal to vaccinate despite the availability of vaccines" [17]. Respondents said to be hesitant to the vaccine if they respond “No” to the question “By the time you get a chance for Covid-19 vaccine, will you take the vaccine without any refusal?”.

Perceived susceptibility COVID-19 infection

Refers to a participant’s subjective perception of the risk of acquiring COVID-19 and is measured as High, Moderate, Low, No risk, or not sure [18].

Perceived severity of COVID-19 infection

Refers to a person’s subjective perception of the seriousness of contracting COVID-19 and measured as High, Moderate, Low, No risk, or not sure [18].

Data processing and analysis

The responses from the participants were downloaded in Excel using Google Forms. The data were checked for completeness and consistency, then compiled and coded. Then, it was exported to STATA version 14.2 statistical software for analysis. A binary logistic regression was employed to identify factors associated with adherence to COVID-19 mitigation measures. Initially, bivariate analysis was done, and variables with a p-value of 0.2 or below were identified as candidates for multivariable analysis. Then, multivariable analysis was done, and the adjusted odd ratio with a 95% confidence interval was computed and interpreted. A p-value of less than 0.05 is the cut-off point for determining the significance of an association. Finally, the result of the study was presented in text and tables.

Data quality assurance

The web-based self-administered questionnaire was pretested by taking 5% of the sample size before the actual data collection period. Afterward, the pretests, amendments to the tool, like formatting were corrected. The tool was first developed in the English language and was translated into the local language (Amharic) with back translation to English to check its consistency. Moreover, Cronbach’s alpha value was calculated to check the tools’ reliability and the value of an item score was 0.892.

Ethics approval and consent to participate

This study was approved by the institutional review board (IRB) of the University of Gondar. Written informed consent was obtained from each participant using communication channels (telegram and email) and those who agreed to participate were included in the study. Respondents were informed that their participation was voluntary and their confidentiality was maintained by avoiding registration of personal identifiers like names on the questionnaire and also, no raw data was given to anyone other than the investigator. In addition, the raw data is secured by a strong computer password.

Results

Socio-demographic characteristics of study participants

From the total 433 samples, 418 participants completed the questionnaire that yielded a 96.5% response rate. The mean age of study participants was 29.95 in the current study. More than half of the participants were under the age category of 26–30 years and nearly two-thirds were males. About 54% were married, 55% BSc and below educational level. The majority of the study participants have a monthly income in the category of 6991–12800 birr. Based on family size, 53.35% have less than or equal to 2 and nearly one thirds (31.58%) have children with school-age (Table 1).
Table 1

Socio-demographic characteristics of study participants (N = 418).

VariablesCategoryFrequencyPercent (%)
Age≤254911.72
26–3023455.98
≥3113532.30
SexFemale12930.86
Male28969.14
Marital statusSingle19446.41
Married22453.59
Educational statusBSc and below23055.02
MSc and above18844.98
Monthly income<6990276.46
6991–1280035785.41
≥12801348.13
Family size≤222353.35
3–412830.62
≥56716.03
School-age childrenNo28668.42
Yes13231.58

COVID-19 related characteristics of study participants

Nearly two-thirds (63.64%) of the participants were socially isolated because of their profession. About 59% underwent the COVID test and 44% were confident in health care services delivered on their institution whereas 45.69% got unclear information by health authorities related to the COVID-19 pandemic. Only100 (23.92%) believe measurements taken by the national government related to COVID-19 preventive measures are adequate. More than half (52.39%) of participants reported that they are at higher risk of COVID-19 infection but 53.35% believe they are at low risk to develop the severe disease if infected with the coronavirus. Nearly two-thirds (63.64%) had good compliance on social isolation if suspected to COVID-19 whereas 57.89% were suspected of COVID-19 diagnosis. About 55% perceive that their health status was very good. Only 3.83% have autoimmune diseases taking steroidal drugs. Nearly 54% of the participants were willing to take the COVID-19 vaccine but about 19% are confident in the current vaccine (Table 2).
Table 2

COVID-19 related characteristics of the study participants (N = 418).

Social isolationNo15236.36
Yes26663.64
Undergone COVID testNo17241.15
Yes24658.85
Confident in health care servicesNot confident19446.41
Confident18444.02
Very confident409.57
Information by health authoritiesClear13432.06
Inconsistent9322.25
Unclear19145.69
Measurements by Gov’tNot very adequate18644.50
Not adequate13231.58
Adequate10023.92
Risk to get COVID-19 infectionLow9622.97
Moderate10324.64
High21952.39
Risk to sever COVID-19 diseaseModerate/high11527.51
Low22353.35
No/not sure8019.14
Households age >60 yearsNo35584.93
Yes6315.07
Compliance to social isolationNo15236.36
Yes26663.64
Suspected COVID-19 DiagnosisNo17642.11
Yes24257.89
Undergone COVID-19 testNo17241.15
Yes24658.85
Perception of your health statusGood18343.78
Very bad71.67
Very good22854.55
Autoimmune problem /taking steroidNo40296.17
Yes163.83
Will you take COVID-19 vaccineNo19245.93
Yes22654.07
Confident in the current COVID-19 vaccineConfident8019.14
Not confident10023.92
Not very confident23055.02
Very confident81.91

Adherence towards COVID-19 mitigation measures

The Adherence towards COVID-19 mitigation measures among health care workers in the current study was 50.24[95%CI (45.44–55.04)]. Adherence to COVID-19 measures was 71.29%, 73.21%, and 56.94% for wearing a mask, washing hands ≥6 times per day based on WHO hand washing rules, and physical distancing of at least 2 meters respectively (Fig 2).
Fig 2

Distribution of adherence of COVID-19 mitigation measures among health care workers in referral hospitals of Amhara regional state of Ethiopia.

Factors associated with adherence of COVID-19 mitigation measures

Binary logistic regression was employed to identify independent factors that can affect the outcome variable. In bivariable analysis, monthly income, hesitancy to take COVID-19 vaccine, age, marital status, undergone COVID-19 test, the information given by health authority, measures taken by the national government, the risk to get COVID-19 disease, risk of severe COVID-19 disease, household age >60 years, suspected to COVID-19 infection, Comorbidity and confident on the current COVID-19 vaccine were associated with the outcome variable. But in multivariable analysis, monthly income, hesitancy to take COVID-19 vaccine, age, undergone COVID-19 test, measures taken by the national government, household aged >60 years, and suspected to COVID-19 infection were statistically significant variables that affected adherence of COVID-19 mitigation measures. Study participants with a monthly income of ≥12801birr adhered to COVID-19 measures 15% taking monthly income of ≤6990 as reference [AOR = 0.15, 95%CI (0.02–0.92)]. Participants who hesitate to take COVID 19 vaccine adhered 10% [AOR = 0.10, 95%CI (0.04–0.25)] as compared to those who don’t hesitate. Those participants with the age group of 26–30 years adhered to mitigation measures 9% [AOR = 0.09, 95%CI (0.02–0.39)] compared to age groups <26 years. Study participants who underwent the COVID-19 test adhered to about 6.6[AOR = 6.64, 95%CI (3.10–14.22)] times more than those who didn’t undergo the test. Participants who believe adequate measurements are taken by the government adhered to about 4.6 [AOR = 4.60, 95%CI (1.66–12.78)] times more than those who believe measurements are not adequate. Participants who believe with no risk of severe COVID-19 disease adhered 16% [AOR = 0.16, 95%CI (0.06-.46)] as compared to those with fear of severe COVID-19 disease. Participants who have households aged >60 years adhered about 7.9[AOR = 7.94, 95%CI (3.14–20.04)] times more than those with no households aged>60 years and those participants suspected to COVID-19 infection adhered to mitigation measures about 5.7 [AOR = 5.74, 95%CI (1.81–18.16)] times more than those who didn’t suspect (Table 3).
Table 3

Factors associated with adherence of COVID-19 mitigation measures among health care workers in referral hospitals of Amhara regional state of Ethiopia (N = 418).

VariablesCategoryCORAORP-value95% CI
Monthly income≤6990111
6991–128000.21*0.290.105(0.06–1.29)
≥128010.18*0.15 0.041 (0.02–0.92)
Hesitancy to COVID 19 vaccineNo111
Yes0.09*0.10 <0.001 (0.04–0.25)
Age<26111
26–300.53*0.09 0.001 (0.02–0.39)
≥310.970.250.065(0.05–1.08)
Marital statussingle111
Married0.72*1.330.422(0.66–2.68)
Undergone COVID-19 19 testYes8.28*6.64 <0.001 (3.10–14.22)
No111
Information health by authoritiesclear0.891.790.250(0.66–4.88)
Inconsistent0.37*0.410.071(0.15–1.07)
Unclear111
Measures by Gov’tNot very adequate111
Not adequate0.29*0.660.299(0.29–1.45)
Adequate1.284.60 0.003 (1.66–12.78)
Risk to get COVID-19 diseaselow111
Moderate0.892.400.136(0.75–7.61)
High3.09*2.130.125(0.81–5.60)
Fear to risk of sever COVID-19 diseaseNo risk0.13*0.16 0.001 (0.06-.46)
Low risk0.57*0.4510.07(0.18–1.08)
Moderate/high risk111
Household with age >60yrsYes1.8 0*7.94 <0.001 (3.14–20.04)
No111
Suspected to COVID-19 infectionYes12.51*5.74 0.003 (1.81–18.16)
No111
ComorbidityNo111
Yes0.140.350.347(0.04–3.08)
Confident on COVID-19 vaccineNot confident0.500.780.618(0.29–2.07)
Confident111

* = variables associated with the outcome variable at p-value<0.2, 1 = reference category of the respected variable.

* = variables associated with the outcome variable at p-value<0.2, 1 = reference category of the respected variable.

Discussion

The current study aimed to determine adherence to COVID-19 mitigation measures and their associated factors. The adherence to COVID-19 mitigation measures among the participants was found to be 50.24%. The highest adherence (73.21%) was reported for handwashing whereas the lowest (56.94%) was reported for physical distancing. The current finding of adherence was lower than the study conducted in Saudi Arabia (82%), the United Kingdom(80%), and the Kingdom of Saudi Arabia(80.9%) [19-21]. The possible reasons for this difference might be the countries’ policy to prevent the pandemic, the monthly income difference of the study participants which might affect buying abilities of face masks, the data collection period differences in which all the studies conducted before the current study when vaccines were not found. But the current finding is more than the studies conducted in Western Ethiopia (22%) and southeast Ethiopia (21.6%) [15, 22]. The possible justification of the differences of the findings might be differences in COVID-19 prevention policies of the respected health institutions in the specified regions even though they are found in the same country. Different independent variables in the current study affected the outcome variable. Monthly income, vaccine hesitancy, age, undergone COVID19 test, measurements taken by the national government, perception of the severity of the disease, presence of households with age>60 years and suspected to COVID-19 diagnosis significantly affected the adherence of COVID-19 measures in different directions. Study participants in the current study with a monthly income of ≥12801birr adhered to COVID-19 measures less than those with a monthly income of ≤6990 birrs. This might be participants with low monthly income could use public transportation which might increase fear to acquire COVID-19 infection and cause them to adhere more [23, 24]. Participants who hesitate to take COVID -19 vaccines adhered lower than those who are volunteers to take the vaccine. The current study finding is supported by different studies conducted in Germany and China [25, 26]. The possible reason could be those who hesitate to take the vaccine might be individuals who believe COVID -19 is not a severe disease and even there is no such disease [27-29]. Study participants with age groups of 26–30 years adhered to mitigation measures lower than those with age groups of <26 years. The current finding is in contradiction with the study conducted in South Ethiopia among the general community [30]. The discrepancy might be due to the current study conducted among health care workers but the previous study was conducted among the general community. The possible justification for the current study would be younger professionals might abide by mitigation measures more than elders due to negligence [31]. The experienced COVID-19 test increased the participants’ adherence in the current study. This might be as the participants who believe the existence of the pandemic is high and resulted to undergo COVID-19 test and consequently adhered to the mitigation measures than those who didn’t experience the COVID-19 test [1, 32]. Similarly, study participants who think that adequate measurements are taken by the national government adhered to mitigation measures more than those who think not taking adequate measurements. This could be those thinking the national government is taking adequate measurement trusted the national policies related to the pandemic and consequently adhered more [33, 34]. Study participants who perceived the severity of the disease as high adhered more than those who perceived no risk. Naturally, those who perceive the disease as severe are more committed to prevent it [35]. Participants who have households aged>60 years adhered more than those with no. The current finding is in line with the study conducted in Slovenia [36] This might be because individuals with age >60 years are at the risk of getting severe complications of the COVID -19 like death [37]. Therefore, those participants with households of age >60 years adhered more to prevent such complications of their households. Another factor that increased the adherence to theCOVID-19 mitigation measures was suspected to COVID-19 infection. This finding is in agreement with the study finding conducted in Congo [38]. This might be as those suspected of the disease would not be allowed to enter the working area and consequently adhere to the preventive measures [39].

Conclusion

This study found lower adherence to COVID-19 mitigation measures among health care workers. Greater monthly income, hesitate to take the vaccine and older age decreased the adherence whereas undergone COVID-19 test, adequate measurement by the government, believing severity of the disease, households with age >60 years and suspected to COVID-19 diagnosis increased the adherence of mitigation measures. It is better to boost the practice of health care workers on the prevention methods of the COVID-19 pandemic in the current study setting since the adherence of the mitigation measures is lower than the recommended.

Limitations of the study

Since this study is cross-sectional, it shares the limitations of a cross-sectional study design. Social desirability bias could be introduced through study participants since the data collection technique was self-administered. To avoid the mentioned bias, the authors recommend doing further investigation using observational checklists. (XLS) Click here for additional data file. (DOCX) Click here for additional data file.

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present. 21 Jan 2022
PONE-D-21-38230
Adherence of Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional state of Ethiopia.
PLOS ONE Dear Dr. Beletech Fenti Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by March 7, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Paavani Atluri Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: ● The name of the colleague or the details of the professional service that edited your manuscript ● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) ● A clean copy of the edited manuscript (uploaded as the new *manuscript* file). 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ. 6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 7. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author. - https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0257373 We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications. Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work. We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough. 8.  Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. since your study is a form of survey study, could you add study map?? to have more description for the reader? 2. correct place for ethics approval and consent to participate subtitle, and no need to write duplicate subtitle 3. No need to describe the study area / objective under discussion again!! 4. duplicate statements under abstract and conclusion Reviewer #2: When you are writing the statement of the problem, it was nice if you put the paragraphs as follows; • Concise description of the problem (severity, which group is affected, the distribution of the problem, what contribute to the problem, the consequences of the problem. what policies, and strategies are in palace to combat the problem , what is known, what is not known, why you are interested in the topic ( what gaps exist) • You can use few studies to describe the problem but it’s recommended to summaries studies with similar findings in one statement Better to put in such way Binary logistic regression was be employed to identify factors associated with adherence of COVID-19 mitigation measures. Initially bivariate analysis was done and variables with p-value of below 0.2 was identified as candidate for multi-variable analysis. Then multi-variable analysis was done and adjusted odd ration was computed and interpreted. A p-value less than 0.05 is cut-off point for determining the significance of association. Result of the study was presented in text, table and graphs. Reviewer #3: None Reviewer #4: I appreciate the authors for doing a research on the current pandemic disease. But I have some concerns. 1. Abstract is OK. 2. Methods: Please provide further detail how Random selection was carried out to select study participants. 3. Please try to provide the detail of the specific questions used to assess adherence level for all the three components. 4. Discussion: The justification provided by the authors on the discrepancy between the studies conducted in other part of the same country may be due to the difference in tool used to assess adherence. Please provide a clear justification why you preferred using a tool with only three components to assess adherence level when others used different tool( discussion part second paragraph line 13-14) 5. In discussion, the author only compared their finding with other studies on the adherence level and no comparisons were made with other studies for factors affecting adherence level. 6. Discussion part should cover the interpretation of the finding, comparison with other studies, explanation for discrepancies if it exists, and the limitation of the study. The discussion part could be more than what the authors provided. Reviewer #5: dear authors thank you for your effort, i have some comments and questions in your work Abstract 1) the conclusion part of the abstract is not based on your finding, its a general kind of conclusion Introduction 2)your in introduction is not well conceptualized, you did not show the gap for doing this research you said "there is no paper locally" but there are number of papers on covid mitigation measures of health workers even in Ethiopia methods 3) you have defined perceived susceptibility and risk of getting disease as the same variables when they actually are very different variable 4)you measured perceived severity and risk of getting severe disease as the same variable when they actually are different variable 5)you measured perceptions categorically which has a lot of limitation, what's your base to categorize perception? i recommend you to treat perception items as continuous variable 6)how do you measured vaccine hesitancy, covid mitigation measures, perceived susceptibility and perceived severity please attach the questionnaire i want to see the questionnaire RESULT PART 7)you have wrongly interpreted the odds ratios that are less than one ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Abass Abdul-Karim Reviewer #4: No Reviewer #5: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
Submitted filename: PONE-D-21-38230 commented.pdf Click here for additional data file. 26 Feb 2022 26/02/2022 Paavani Atluri, PLOS ONE Dear Paavani Atluri, Subject: Submission of revised manuscript entitled as “Adherence of Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional state of Ethiopia” (PONE-D-21-38230). Thank you for email dated on January 21/2022 enclosing the Editorial member’s and the reviewer’s comments. We have carefully revised the manuscript and incorporated their comments accordingly. Our responses are given in point-by-point response below. We hope the revised version is suitable for publication and look forward to hearing from you in due courses. Sincerely Beletech Fentie University of Gondar, College of Medicine and health Sciences, School of Nursing, Department of pediatrics and child health nursing. Point by point responses to Editorial Board Member’s and Reviewers’ comments. Title of paper: Adherence of Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional state of Ethiopia Editorial comments: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming Authors Response: Thank you very much for your constructive comments and suggestions. We tried to incorporate your comments accordingly and we hope the manuscript meets PLOS ONE’s style requirements. 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. Authors’ Response: Thank you very much for your constructive comments. Written informed consent was obtained from each participant using communication channels (telegram and email) and those who agreed to participate were included in the study and this information is provided in the Ethics approval and consent to participate section of the manuscript. This study did not include the minors. 3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Authors’ Response: Thank you very much for your constructive comments. We tried to address the comments in the manuscript. Since the authors are in low income country to cover the cost, online grammar checker was used to correct the spelling and grammar errors (Grammarly.com) 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. Authors’ Response: Thank you very much for your comments. We have uploaded the minimal anonymized data set necessary to replicate our study findings as Supporting Information file. 5. PLOS requires an ORCID ID for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Authors’ Response: Thank you very much for your comment. The corresponding author has validated her ORCID ID in Editorial Manager. 6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. Authors’ Response: Thank you very much for your comment. We deleted the ethics statement that was included other than the methods section in the manuscript. 7. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author. - https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0257373 Authors’ Response: Thank you very much for your comments. We tried to revise the manuscript and rephrase the duplicated text and cite the sources. The published article you mentioned (https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0257373) is conducted in the general community but the current study is conducted in health care providers which is different population in the general community(i.e The study populations of the already published article and the current manuscript is totally different). Therefore, we think there is no duplication. 8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice Authors’ Response: Thank you very much for your comments. We have assessed the references as much we can and the references are correct and there is no retracted article cited. Reviewer #1: 1. Since your study is a form of survey study, could you add study map?? to have more description for the reader? Author’s response: • Based on the comment, the authors incorporated a study map in the revised manuscript. 2. Correct place for ethics approval and consent to participate subtitle, and no need to write duplicate subtitle. Author’s response: • Thank you for the comments. • Based on the comment, the authors removed the ethics section from the declaration part and only incorporated it in the method section. 3. No need to describe the study area / objective under discussion again!! Author’s response: • Thank you. The authors removed it in the revised manuscript. 4. Duplicate statements under abstract and conclusion. Author’s response: • Thank you for your concern. In the revised manuscript, the authors rephrase the idea in the abstract section. Reviewer #2: 1. When you are writing the statement of the problem, it was nice if you put the paragraphs as follows; • Concise description of the problem (severity, which group is affected, the distribution of the problem, what contribute to the problem, the consequences of the problem. what policies, and strategies are in palace to combat the problem , what is known, what is not known, why you are interested in the topic ( what gaps exist). Authors Response: Thank you very much for your constructive comments and suggestions. We tried to address your comments and suggestions accordingly in the manuscript. 2. Better to put in such way Binary logistic regression was be employed to identify factors associated with adherence of COVID-19 mitigation measures. Initially bivariate analysis was done and variables with p-value of below 0.2 were identified as candidate for multi-variable analysis. Then multi-variable analysis was done and adjusted odd ration was computed and interpreted. A p-value less than 0.05 is cut-off point for determining the significance of association. Result of the study was presented in text, table and graphs. Author’s response: Based on the comments, the authors revised this paragraph under the subheading of the “Data processing and analysis” section of the manuscript. Reviewer #3: None Author’s response: Reviewer 3 didn't have any comments to the authors regarding the manuscript. Reviewer #4: I appreciate the authors for doing a research on the current pandemic disease. But I have some concerns. Author’s response: •Thank you for your appreciation and positive feedback. 1. Abstract is OK. Author’s response: Thank you. 2. Methods: Please provide further detail how Random selection was carried out to select study participants. Author’s response: Thank you for your concern. Based on the comments, the authors incorporated the details of randomization in the revised manuscript. 3. Please try to provide the detail of the specific questions used to assess adherence level for all the three components. Authors Response: Thank you very much for your constructive comments and suggestions. We tried to address all the issues raised in operational definition part of the revised manuscript. 4. Discussion: The justification provided by the authors on the discrepancy between the studies conducted in other part of the same country may be due to the difference in tool used to assess adherence. Please provide a clear justification why you preferred using a tool with only three components to assess adherence level when others used different tool (discussion part second paragraph line 13-14) Authors Response: Thank you very much for your constructive comments. The previous studies used more adherence components since they were conducted in the initial phase of the pandemic (like there were lockdown, no public transportation, satay at home rules, mass gathering and etc. in the world). Since stay at home, restriction of public transportation, mass gathering and any lockdown are removed; we used the three major components used to prevent the COVID- 19 pandemic. The three components are also highly recommended by world health organization and many other health authorities and organization including Ethiopian ministry of health. 5. In discussion, the author only compared their finding with other studies on the adherence level and no comparisons were made with other studies for factors affecting adherence level. Authors’ Response: Thank you very much for your constructive comments. In some extent, we tried to address the comment in the manuscript, but as our search we didn’t get any similar factors associated to adherence in other articles conducted in health care providers. That is why we left not discussed the factors variables. Instead, we tried to show scientific facts why these factors influence the adherence. 6. Discussion part should cover the interpretation of the finding, comparison with other studies, explanation for discrepancies if it exists, and the limitation of the study. The discussion part could be more than what the authors provided. Authors Response: Thank you very much for your constructive comments. We tried to elaborate the discussion part as per your comment and suggestion Reviewer#5 Dear authors, thank you for your effort, I have some comments and questions in your work Author’s response: Thank you for your feedback. Abstract: 1) The conclusion part of the abstract is not based on your finding, it’s a general kind of conclusion Author’s response: Thank you. We revised and retyped it based on the findings of this study. Introduction: 2) Your introduction is not well conceptualized, you did not show the gap for doing this research, you said "there is no paper locally" but there are number of papers on covid mitigation measures of health workers even in Ethiopia Authors Response: Thank you very much for your constructive comment. We tried to address the comments in the manuscript. But still we couldn’t get any article published in the study setting among health care providers even in Ethiopia. Methods: 3) You have defined perceived susceptibility and risk of getting disease as the same variables when they actually are very different variable Author’s response: According to the health belief model (HBM), • Perceived susceptibility is defined as a person’s subjective perception about their chance or risk of getting a certain condition, in this case, COVID-19. • This means the literal definition of “Perceived susceptibility” is “perceived risk of getting a disease”. • That was why the authors used the phrase “Perceived susceptibility/risk of getting COVID-infection”, which is to mean “perceived susceptibility of getting COVID-infection” or “perceived risk of getting COVID-infection”. • In short, based on the definition of HBM, the authors used these two terms interchangeably. • But, to avoid ambiguity, the authors used only “perceived susceptibility” in the revised manuscript. 4) You measured perceived severity and risk of getting severe disease as the same variable when they actually are different variable Author’s response: • According to HBM, “perceived severity” refers to a person’s belief about the seriousness or severity of a disease. • i.e. Perceived severity of COVID-19 infection = Perceived risk of developing sever COVID-19 infection. • That was why the authors used the term “perceived severity/risk of developing the severe disease”. • But, to avoid ambiguity, the authors used only “perceived severity” in the revised manuscript. 5) You measured perceptions categorically which has a lot of limitation, what's your base to categorize perception? I recommend you to treat perception items as continuous variable Author’s response: • Thank you for your recommendation. But, we assessed it by using the Likert scale, as other literature has used before. After that, re-categorization was considered in a few variables if the chi-square assumption was not fulfilled. 6) How do you measured vaccine hesitancy, COVID-19 mitigation measures, perceived susceptibility and perceived severity please attach the questionnaire I want to see the questionnaire Author’s response: • The way of measuring these variables was stated under the subheading “Operational Definition” of the method section. • Based on your request, we attached the questionnaire during the re-submission of the revised manuscript as a “supplementary file” . Result: 7) You have wrongly interpreted the odds ratios that are less than one Author’s response: We think the interpretations of the Odds rations are correct. For example:- AOR=0.15 means study participants adhered 15% to mitigation measures. In another way, it can be interpreted as study participants were 85% less likely adhere to mitigation measures of COVID-19. That is why we used one of the two ways of interpretations. If authors are mistaken, they can correct with reasonable justifications you will give us. Submitted filename: PLOS point by point response .docx Click here for additional data file. 22 Jul 2022 Adherence to Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional State of Ethiopia PONE-D-21-38230R1 Dear Dr. Fentie, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Paavani Atluri Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: No ********** 28 Jul 2022 PONE-D-21-38230R1 Adherence to Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional State of Ethiopia Dear Dr. Fentie: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Paavani Atluri Academic Editor PLOS ONE
  27 in total

1.  COVID-19 Prevention Practices and Determinant Factors Among Healthcare Professionals Working in Hospitals of South Gondar Zone, Northwestern Ethiopia.

Authors:  Zebader Walle; Gete Berihun; Awoke Keleb; Daniel Teshome; Leykun Berhanu
Journal:  J Multidiscip Healthc       Date:  2021-08-22

2.  Psychological correlates of COVID-19 conspiracy beliefs and preventive measures: Evidence from Turkey.

Authors:  Sinan Alper; Fatih Bayrak; Onurcan Yilmaz
Journal:  Curr Psychol       Date:  2020-06-29

3.  COVID-19-Related Knowledge, Attitude and Practice Among Hospital and Community Pharmacists in Addis Ababa, Ethiopia.

Authors:  Zelalem Tilahun Tesfaye; Malede Berihun Yismaw; Zenebe Negash; Akeberegn Gorems Ayele
Journal:  Integr Pharm Res Pract       Date:  2020-08-24

4.  Fighting COVID-19 Misinformation on Social Media: Experimental Evidence for a Scalable Accuracy-Nudge Intervention.

Authors:  Gordon Pennycook; Jonathon McPhetres; Yunhao Zhang; Jackson G Lu; David G Rand
Journal:  Psychol Sci       Date:  2020-06-30

5.  Magnitude and associated factors of medication administration error among nurses working in Amhara Region Referral Hospitals, Northwest Ethiopia.

Authors:  Enyew Getaneh Mekonen; Mignote Hailu Gebrie; Senetsehuf Melkamu Jemberie
Journal:  J Drug Assess       Date:  2020-11-10

6.  Predictors of adherence to COVID-19 prevention measure among communities in North Shoa Zone, Ethiopia based on health belief model: A cross-sectional study.

Authors:  Sisay Shewasinad Yehualashet; Kokebe Kefelegn Asefa; Alemayehu Gonie Mekonnen; Belete Negess Gemeda; Wondimenh Shibabaw Shiferaw; Yared Asmare Aynalem; Awraris Hailu Bilchut; Behailu Tariku Derseh; Abinet Dagnaw Mekuria; Wassie Negash Mekonnen; Wondesen Asegidew Meseret; Sisay Shine Tegegnework; Akine Eshete Abosetegn
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

7.  Compliance towards infection prevention measures among health professionals in public hospitals, southeast Ethiopia: a cross-sectional study with implications of COVID-19 prevention.

Authors:  Demisu Zenbaba; Biniyam Sahiledengle; Abulie Takele; Yohannes Tekalegn; Ahmed Yassin; Birhanu Tura; Adem Abdulkadir; Edao Tesa; Alelign Tasew; Gemechu Ganfure; Genet Fikadu; Kenbon Seyoum; Mohammedawel Abduku; Tesfaye Assefa; Garoma Morka; Makida Kemal; Adisu Gemechu; Kebebe Bekele; Abdi Tessema; Safi Haji; Gebisa Haile; Alemu Girma; Mohammedaman Mama; Asfaw Negero; Eshetu Nigussie; Habtamu Gezahegn; Daniel Atlaw; Tadele Regasa; Heyder Usman; Adem Esmael
Journal:  Trop Med Health       Date:  2021-04-16

8.  Adherence towards COVID-19 mitigation measures and its associated factors among Gondar City residents: A community-based cross-sectional study in Northwest Ethiopia.

Authors:  Zelalem Nigussie Azene; Mehari Woldemariam Merid; Atalay Goshu Muluneh; Demiss Mulatu Geberu; Getahun Molla Kassa; Melaku Kindie Yenit; Sewbesew Yitayih Tilahun; Kassahun Alemu Gelaye; Habtamu Sewunet Mekonnen; Abere Woretaw Azagew; Chalachew Adugna Wubneh; Getaneh Mulualem Belay; Nega Tezera Asmamaw; Chilot Desta Agegnehu; Telake Azale; Animut Tagele Tamiru; Bayew Kelkay Rade; Eden Bishaw Taye; Asefa Adimasu Taddese; Zewudu Andualem; Henok Dagne; Kiros Terefe Gashaye; Gebisa Guyasa Kabito; Tesfaye Hambisa Mekonnen; Sintayehu Daba; Jember Azanaw; Tsegaye Adane; Mekuriaw Alemayeyu
Journal:  PLoS One       Date:  2020-12-30       Impact factor: 3.240

9.  Adherence towards COVID-19 prevention measures and associated factors in Hossana town, South Ethiopia, 2021.

Authors:  Temesgen Tamirat; Lonsako Abute
Journal:  Int J Clin Pract       Date:  2021-12-05       Impact factor: 3.149

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.